Related Experiment Video
Updated: Jan 30, 2026

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos
Published on: December 7, 2018
ADHD in children and youth: Part 3-Assessment and treatment with comorbid ASD, ID, or prematurity
Brenda Clark1, Stacey A Bélanger1
1Canadian Paediatric Society, Mental Health and Developmental Disabilities Committee, Ottawa, Ontario.
Insights
Canadian guidelines offer evidence-based ADHD care standards for children and youth. This review covers diagnosis, common presentations, genetics, and treatment for attention-deficit hyperactivity disorder (ADHD), including associated conditions.
Area of Science:
- Neurodevelopmental disorders
- Pediatric medicine
- Clinical evidence synthesis
Background:
- Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder impacting children and youth.
- Existing clinical evidence requires systematic review to establish standardized care protocols.
- Canadian Paediatric Society developed three position statements based on literature reviews.
Purpose of the Study:
- To summarize current clinical evidence for ADHD.
- To establish a standard of care for ADHD in Canada.
- To aid clinicians in evidence-based decision-making for pediatric ADHD management.
Main Methods:
- Systematic literature reviews were conducted.
- Focus on Part 3: associated autism spectrum disorder, intellectual disability, and prematurity.
- Recommendations based on guidelines, literature, and expert consensus.
Main Results:
- Comprehensive review of ADHD diagnostic challenges and presentations.
- Exploration of genetic factors in ADHD.
- Evaluation of treatment options, including physical activity benefits.
Conclusions:
- Evidence-based recommendations for ADHD care are provided.
- Standardized care aims to enhance outcomes for children and youth with ADHD.
- Part 3 addresses complex cases involving co-occurring conditions.
Abstract:
Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD,2) Establish a standard for ADHD care, and3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 3, which focuses on associated autism spectrum disorder, intellectual disability, and prematurity, include the challenges of diagnostic assessment, common presentations, the role of genetics, and treatment, including the benefits of physical activity. Recommendations are based on current guidelines, evidence from the literature, and expert consensus.
Related Concept Videos
Drug Dosing: Infants and Children
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

